Alogliptin/metforminAlternative Names: Alogliptin benzoate/metformin hydrochloride; Inisync; KAZANO; Kazano; Metformin/alogliptin; Nesina Met; SYR-322/metformin; SYR-322MET; TAK-322/metformin; Vipdomet
Latest Information Update: 29 Sep 2016
At a glance
- Originator Takeda
- Class Antihyperglycaemics; Biguanides; Piperidines; Pyrimidinones; Small molecules
- Mechanism of Action AMP activated protein kinase stimulants; CD26 antigen inhibitors; Gluconeogenesis inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Type 2 diabetes mellitus